Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Areas with lower population density have not seen the same slowdown as urban areas.
Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.
The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat.
The Arlington location is one of over 35 clinics in the South operated by CAN Community Health.
Some state Medicaid programs and prison systems still restrict treatment based on substance use or stage of liver disease.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
A recent study in Boston found that only 6% of people at detox centers who tested positive for either virus received follow-up medical care.
Only three states are expected to meet the 2030 goal.
A revamped National Harm Reduction Coalition tackles the “racist war on drugs” and advocates for people who use drugs.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
290 million people have viral hepatitis and don’t know it. Raise awareness with a virtual video relay.
Sofosbuvir and daclatasvir were linked to faster recovery and improved survival in studies in Iran.
New York collaborators will also address the related epidemics of hepatitis C, sexually transmitted infections and opioid use.
Second of a two-part series about incarceration and health
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.